Maynard Um
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $136 at Guggenheim
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
-
-
-
-
-
-
-
Incyte (INCY) PT Raised to $103 at Morgan Stanley
-
-
-
-
-
-
-
William Blair on Incyte (INCY): 'encouraged' by Ph3 data and deepened responses
-
-
-
-
-
-
-
Jefferies Downgrades Incyte (INCY) to Hold
-
-
-
-
-
-
-
H.C. Wainwright Starts Incyte (INCY) at Buy
-
-
-
-
-
-
-
Japan approves Incyte's Minjuvi for follicular lymphoma treatment
-
407,032 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

